Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Janux Therapeutics Inc (JANX)

187 + Investors. Track Smart Money conviction in JANX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +12
Streak
2Q ▲
Buyers last Q
57%

Smart Money Signals — JANX

Based on 187 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added JANX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 88% of 3.0Y peak

88% of all-time peak
187 funds currently hold this stock — 88% of the 3.0-year high of 212 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +4% more funds vs a year ago

fund count last 6Q
+8 new funds entered over the past year (+4% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 57% buying

113 buying86 selling
Last quarter: 113 funds bought or added vs 86 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~45 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 14 → 21 → 49 → 45. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 33% long-term, 36% new

■ 33% conviction (2yr+) ■ 31% medium ■ 36% new
Of the 187 current holders: 62 (33%) held >2 years, 58 held 1–2 years, and 67 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
🚀

Acceleration phase — new buyers rushing in

21 → 14 → 21 → 49 → 45 new funds/Q
New funds entering each quarter: 14 → 21 → 49 → 45. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 34% veterans, 34% new entrants

■ 34% veterans ■ 33% 1-2yr ■ 34% new
Of 197 current holders: 66 (34%) held 2+ years, 65 held 1–2 years, 66 (34%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 31% AUM from major funds

31% from top-100 AUM funds
41 of 187 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — JANX

In 2026 Q1, 113 hedge funds were net buyers of JANX (45 opened a new position, 68 added to an existing one), while 86 reduced or exited (53 trimmed, 33 sold completely) — a 57% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 31% of total institutional value in JANX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +12 funds (more new holders than closures). Total institutional holders: 187.

Hedge Fund Ownership: JANX

How many hedge funds hold JANX — quarterly history vs. share price
Quarterly hedge fund ownership of JANX vs. share price

Market Analysis: JANX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: JANX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Janux Therapeutics Inc (JANX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much JANX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
JANX
-2.4%
XLV
+4.9%

JANX outperformed XLV by -7.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
JANX
-2.4%
XLV
+6.0%

Since the filing became public, JANX outperformed XLV by -8.4% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

27 top-rated funds 2 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
2.2
/ 10
conviction
Hedge Fund Positioning: JANX
187 + Investors

Track Smart Money conviction in JANX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 187 175 6.86%
13F Shares 60M 64M -5.07%
Total Value $828M $865M -4.38%
New Positions 45 49 -4
Increased Positions 64 68 -4
Closed Positions 33 40 -7
Reduced Positions 52 40 +12
Total Calls 8 9 -11.11%
Total Puts 4 6 -33.33%
PUT/CALL Ratio 0.5 0.67 Bullish

Statistics: JANX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

187 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in JANX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 JANX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Prosight Management, LP 8.09% 3,550,000 $49.3M
2 Rangeley Capital, LLC 1.65% 122,500 $1.7M
3 Ra Capital Management, L.P. 1.65% 11,189,693 $155.5M
4 Lion Point Capital, LP 1.58% 19,000 $264K
5 BML Capital Management, LLC 1.38% 154,961 $2.2M
6 TCG Crossover Management, LLC 0.71% 1,789,617 $24.9M
7 Logos Global Management LP 0.69% 1,000,000 $13.9M
8 Irenic Capital Management LP 0.69% 765,804 $10.6M
9 Nano Cap New Millennium Growth Fund L P 0.51% 39,500 $549K
10 Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 0.44% 376,496 $5.2M
11 Nantahala Capital Management, LLC 0.41% 809,914 $11.3M
12 Tang Capital Management LLC 0.35% 500,000 $7.0M
13 Rock Springs Capital Management LP 0.30% 367,009 $5.1M
14 Orbimed Advisors LLC 0.27% 983,600 $13.7M
15 Deep Track Capital, LP 0.27% 1,187,290 $16.5M
16 ADAR1 Capital Management, LLC 0.24% 298,546 $4.1M
17 HighVista Strategies LLC 0.19% 49,383 $686K
18 Stonepine Capital Management, LLC 0.11% 20,000 $278K
19 Headlands Technologies LLC 0.10% 61,633 $857K
20 Diadema Partners LP 0.07% 31,600 $439K
21 Virtus Investment Advisers, LLC 0.07% 17,821 $248K
22 Readystate Asset Management LP 0.07% 109,425 $1.5M
23 Bridgefront Capital, LLC 0.07% 19,692 $274K
24 Oxford Asset Management LLP 0.07% 11,359 $158K
25 Alyeska Investment Group, L.P. 0.06% 1,601,089 $22.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Janux Therapeutics Inc (JANX)

What does the Smart Money Trend signal show for JANX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added JANX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for JANX?

Slight buying edge — 57% buying: Last quarter: 113 funds bought or added vs 86 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for JANX holders?

Strong quality — 31% AUM from major funds: 41 of 187 holders rank in the top 100 by AUM, accounting for 31% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held JANX?

Mixed — 33% long-term, 36% new: Of the 187 current holders: 62 (33%) held >2 years, 58 held 1–2 years, and 67 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Janux Therapeutics Inc (JANX) following the 2026 Q1 hedge fund 13F filings?

As of today, JANX has moved -2.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -8.4%. Since the quarter end (March 31, 2026), JANX has gained -2.4% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →